Clinical Cancer Research

Oncology & Cancer

Researchers develop blood test for early-stage ovarian cancer

High-grade serous ovarian carcinoma (HGSOC) is the most common type of ovarian cancer. It is also the most lethal form, in part because clinicians do not have effective ways to screen women for it during the cancer's early ...

Oncology & Cancer

Chemotherapy may boost immunotherapy power in ovarian cancer

Women with advanced ovarian cancer may benefit more from immunotherapy drug treatments if they are given straight after chemotherapy, according to a new study published in Clinical Cancer Research today.

page 6 from 40